Seaport Therapeutics (SPTX) is trading up at $18.52 (+0.54%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.
| Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|
| Income statement | ||||
| Operating income | −$16.2M | −$18.5M | −$27.5M | −$65.8M |
| Net income | −$13.1M | −$15.1M | −$25.4M | −$62.6M |
| EPS (diluted) | −$5.65 | −$6.40 | −$10.34 | −$1.78 |
| Balance sheet | ||||
| Cash and equivalents | — | — | $52.9M | $64.2M |
| Total assets | — | — | $227.7M | $441.7M |
| Total liabilities | — | — | $18.0M | $19.1M |
| Shareholders' equity | −$36.2M | −$49.5M | −$115.6M | $422.6M |
| Cash flow | ||||
| Operating cash flow | −$20.2M | −$15.3M | −$20.2M | −$26.1M |
| Capital expenditure | $54.0K | $269.0K | $0 | $0 |
| Free cash flow | −$20.3M | −$15.6M | −$20.2M | −$26.1M |
From Seaport Therapeutics's 10-Q filings with the SEC. Each period shows the latest figure the company has reported for it, including restatements. Filings on SEC EDGAR →
No recent news mentioning Seaport Therapeutics in our feed yet.